These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2505718)

  • 1. [Tolerance and safety of the use of perindopril].
    Santoni JP; Richard C; Pouyollon F; Castaings C; Brown C
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():87-92. PubMed ID: 2505718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance and safety of perindopril.
    Santoni JP; Richard C; Pouyollon F; Castaings C; Brown C
    Clin Exp Hypertens A; 1989; 11 Suppl 2():605-17. PubMed ID: 2691132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and acceptability of perindopril.
    Brown CL
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():51-5; discussion 55-6. PubMed ID: 2283654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [First intention treatment of arterial hypertension. Effectiveness and safety of perindopril].
    Santoni JP; Bizot-Espiard JG; Brown C
    Ann Cardiol Angeiol (Paris); 1989 Sep; 38(7 Pt 2):477-82. PubMed ID: 2686525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Volume of the extracellular liquid and renal function during short-term administration of angiotensin converting enzyme inhibitors in essential hypertension].
    Samà B; Semplicini A; Buzzacarini F; Rubino N; Marzola M; Mozzato MG; Casolino P; Pessina AC
    G Ital Cardiol; 1989 May; 19(5):428-32. PubMed ID: 2670657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term tolerance of perindopril in hypertensive patients with impaired renal function.
    Dratwa M; Sennesael J; Taillard F; Baguet F; Suc JM; Lins RL; Lameire N
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S40-4. PubMed ID: 1725201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of inhibitors of conversion enzymes in elderly subjects. The example of perindopril].
    Forette F; McClaran JM; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():79-85. PubMed ID: 2505717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure.
    Fliser D; Rett K; Hübinger A; Ritz E
    Nephrol Dial Transplant; 1995; 10(5):643-7. PubMed ID: 7566576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
    Naelten G; Liu KL; Chapuis B; Lo M
    Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with an angiotensin converting enzyme inhibitor may increase the nephrotoxicity of gentamicin in rats].
    Morin JP; Thomas N; Toutain H; Borghi H; Fillastre JP
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):652-6. PubMed ID: 2797891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of perindopril on renal haemodynamics and natriuresis in essential hypertension.
    Chaignon M; Barrou Z; Ayad M; Lucsko M; Aubert P; Perret L; Guedon J
    J Hypertens Suppl; 1988 Dec; 6(3):S61-4. PubMed ID: 3225690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy.
    Bönner G; Lederle RM; Scholze J; Stumpe KO
    Arzneimittelforschung; 1993 Aug; 43(8):852-5. PubMed ID: 8216441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors after renal transplantation.
    Bravo P; Felgueiras J; Santos C; Oliveira C; Ponce P
    Transplant Proc; 2008 Apr; 40(3):740-2. PubMed ID: 18455003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
    Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A
    Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perindopril: first-line treatment for hypertension.
    Zanchetti A; Desche P
    Clin Exp Hypertens A; 1989; 11 Suppl 2():555-73. PubMed ID: 2691129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study].
    Widimský J; Fedelesová V; Uhlír O
    Vnitr Lek; 1995 Jul; 41(7):441-4. PubMed ID: 7571476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.